524 related articles for article (PubMed ID: 14754386)
21. [Pharmaco-economic evaluation of Ginkgo special extract EGb 761 for dementias in Austria].
Hörr R; Kieser M
Wien Med Wochenschr; 2002; 152(15-16):427-31. PubMed ID: 12244892
[TBL] [Abstract][Full Text] [Related]
22. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial.
van Dongen M; van Rossum E; Kessels A; Sielhorst H; Knipschild P
J Clin Epidemiol; 2003 Apr; 56(4):367-76. PubMed ID: 12767414
[TBL] [Abstract][Full Text] [Related]
23. Influence of the severity of cognitive impairment on the effect of the Gnkgo biloba extract EGb 761 in Alzheimer's disease.
Le Bars PL; Velasco FM; Ferguson JM; Dessain EC; Kieser M; Hoerr R
Neuropsychobiology; 2002; 45(1):19-26. PubMed ID: 11803237
[TBL] [Abstract][Full Text] [Related]
24. [A comparison of cholinesterase inhibitors and ginkgo extract in treatment of Alzheimer dementia].
Schreiter Gasser U; Gasser T
Fortschr Med Orig; 2001 Nov; 119(3-4):135-8. PubMed ID: 11789125
[TBL] [Abstract][Full Text] [Related]
25. The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial.
van Dongen MC; van Rossum E; Kessels AG; Sielhorst HJ; Knipschild PG
J Am Geriatr Soc; 2000 Oct; 48(10):1183-94. PubMed ID: 11037003
[TBL] [Abstract][Full Text] [Related]
26. Plant-based nutraceutical interventions against cognitive impairment and dementia: meta-analytic evidence of efficacy of a standardized Gingko biloba extract.
Solfrizzi V; Panza F
J Alzheimers Dis; 2015; 43(2):605-11. PubMed ID: 25352453
[TBL] [Abstract][Full Text] [Related]
27. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF
JAMA; 1997 Oct 22-29; 278(16):1327-32. PubMed ID: 9343463
[TBL] [Abstract][Full Text] [Related]
28. Ginkgo Biloba for Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Yang G; Wang Y; Sun J; Zhang K; Liu J
Curr Top Med Chem; 2016; 16(5):520-8. PubMed ID: 26268332
[TBL] [Abstract][Full Text] [Related]
29. Ginkgo biloba for cognitive impairment and dementia.
Birks J; Grimley EV; Van Dongen M
Cochrane Database Syst Rev; 2002; (4):CD003120. PubMed ID: 12519586
[TBL] [Abstract][Full Text] [Related]
30. Long-term treatment with Ginkgo biloba extract EGb 761 improves symptoms and pathology in a transgenic mouse model of Alzheimer's disease.
Liu X; Hao W; Qin Y; Decker Y; Wang X; Burkart M; Schötz K; Menger MD; Fassbender K; Liu Y
Brain Behav Immun; 2015 May; 46():121-31. PubMed ID: 25637484
[TBL] [Abstract][Full Text] [Related]
31. A 26-week analysis of a double-blind, placebo-controlled trial of the ginkgo biloba extract EGb 761 in dementia.
Le Bars PL; Kieser M; Itil KZ
Dement Geriatr Cogn Disord; 2000; 11(4):230-7. PubMed ID: 10867450
[TBL] [Abstract][Full Text] [Related]
32. The efficacy of Ginkgo special extract EGb 761 in patients with tinnitus.
Morgenstern C; Biermann E
Int J Clin Pharmacol Ther; 2002 May; 40(5):188-97. PubMed ID: 12051570
[TBL] [Abstract][Full Text] [Related]
33. Ginkgo extract or cholinesterase inhibitors in patients with dementia: what clinical trials and guidelines fail to consider.
Schulz V
Phytomedicine; 2003; 10 Suppl 4():74-9. PubMed ID: 12807348
[TBL] [Abstract][Full Text] [Related]
34. [Delay in progression of dependency and need of care of dementia patients treated with Ginkgo special extract EGb 761].
Haan J; Hörr R
Wien Med Wochenschr; 2004 Nov; 154(21-22):511-4. PubMed ID: 15638069
[TBL] [Abstract][Full Text] [Related]
35. Long-term treatment with standardized Ginkgo biloba extract (EGb 761) attenuates cognitive deficits and hippocampal neuron loss in a gerbil model of vascular dementia.
Rocher MN; Carré D; Spinnewyn B; Schulz J; Delaflotte S; Pignol B; Chabrier PE; Auguet M
Fitoterapia; 2011 Oct; 82(7):1075-80. PubMed ID: 21820038
[TBL] [Abstract][Full Text] [Related]
36. Ginkgo biloba--an appraisal.
Dubey AK; Shankar PR; Upadhyaya D; Deshpande VY
Kathmandu Univ Med J (KUMJ); 2004; 2(3):225-9. PubMed ID: 16400219
[TBL] [Abstract][Full Text] [Related]
37. A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: neuropsychological findings.
Mix JA; Crews WD
Hum Psychopharmacol; 2002 Aug; 17(6):267-77. PubMed ID: 12404671
[TBL] [Abstract][Full Text] [Related]
38. No alteration in the PFA-100 in vitro bleeding time induced by the Ginkgo biloba special extract, EGb 761, in elderly patients with mild cognitive impairment.
Halil M; Cankurtaran M; Yavuz BB; Ozkayar N; Ulger Z; Dede DS; Shorbagi A; Buyukasik Y; Haznedaroglu IC; Arogul S
Blood Coagul Fibrinolysis; 2005 Jul; 16(5):349-53. PubMed ID: 15970719
[TBL] [Abstract][Full Text] [Related]
39. Memantine versus Ginkgo biloba Extract: A Comparative Study on Cognitive Dysfunction Treatment in a Novel Rat Model.
Allam EAH; Assi AA; Badary DM; Farrag MMY; Nicola MA
Planta Med; 2024 Apr; 90(4):286-297. PubMed ID: 38286405
[TBL] [Abstract][Full Text] [Related]
40. Association of Alzheimer's disease onset with ginkgo biloba and other symptomatic cognitive treatments in a population of women aged 75 years and older from the EPIDOS study.
Andrieu S; Gillette S; Amouyal K; Nourhashemi F; Reynish E; Ousset PJ; Albarede JL; Vellas B; Grandjean H;
J Gerontol A Biol Sci Med Sci; 2003 Apr; 58(4):372-7. PubMed ID: 12663701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
